Pharmacologic inhibition of cathepsin L ameliorates disease and enhances survival by disrupting reovirus assembly, highlighting cathepsins as modulators of viral infection severity and potential therapeutic targets [118]. The gene discussed is CTSS; the disease is viral infectious disease.